ClassID:

91378

C07C43/1787 - CPC Classification

Classification description:

Ethers; Compounds having groups, groups or groups; Ethers having all ether-oxygen atoms bound to acyclic carbon atoms; Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and having unsaturation outside the aromatic rings

Recent Application in this class:
#1
20210032198
2021-02-04

Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex

#2
20200270194
2020-08-27

Method of preparing trisubstituted ethylene compounds

#3
20180065908
2018-03-08

Chain multiyne compound, preparation method and application thereof

#4
20180023001
2018-01-25

COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE

#5
20150203445
2015-07-23

Compounds for use as inhibitors of alternative oxidase or cytochrome BC1 complex

#6
20150148301
2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#7
20130267588
2013-10-10

HYDROXYTYROSOL ETHERS

#8
20120329757
2012-12-27

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#9
20110189212
2011-08-04

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#10
20110097350
2011-04-28

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#11
20100286401
2010-11-11

Ligand iron catalysts for selective hydrogenation

#12
20100048515
2010-02-25

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#13
20090209775
2009-08-20

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#14
20080261865
2008-10-23

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#15
20070099868
2007-05-03

Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders

#16
20050288525
2005-12-29

Reagents for asymmetric allylation, aldol, and tandem aldol and allyation reactions

#17
20050272813
2005-12-08

Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

#18
20050124746
2005-06-09

Pentabromobenzyl alkyl ethers and their use as fire retardants

#19
16559912
2020-12-15

Process to make aromatic enol ethers and olefin isomers of aromatic enol ethers

#20
16559842
2020-12-08

Aromatic enol ethers